drugset / Trial / NCT05478473
Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma
NaSingle-groupOpen-labelTreatment
Summary
The study was a single-arm study designed to evaluate the efficacy and safety of Chidamide combined with Toripalimab.
Timeline
- Start
- 2022-10-27
- Primary completion
- 2023-08
- Completion
- 2024-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Toripalimab | Monoclonal antibody | 240 mg | Intravenous |
| Subject | Tucidinostat | Small molecule | 30 mg | Oral |